ITIL-168 in Advanced Melanoma
Trial details
- Registry ID
- NCT05050006
- Drugs studied
- ITIL-168
TrialRedline tracks 1 clinical trial sponsored by Instil Bio: 1 Phase 2.
Company identity has not yet been verified
| Trial | Drugs studied | Status | Primary completion |
|---|---|---|---|
| ITIL-168 in Advanced MelanomaNCT05050006 | ITIL-168 | Terminated | 2023-02-27Actual |
Names as written in the registry records.